company background image
MCOV B logo

Medicover OM:MCOV B Stock Report

Last Price

SEK 245.00

Market Cap

SEK 36.8b

7D

1.9%

1Y

25.1%

Updated

13 May, 2025

Data

Company Financials +

Medicover AB (publ)

OM:MCOV B Stock Report

Market Cap: SEK 36.8b

MCOV B Stock Overview

Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details

MCOV B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance4/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 57.6% below our estimate of its fair value

Earnings are forecast to grow 29.14% per year

Earnings grew by 37.2% over the past year

Risk Analysis

Interest payments are not well covered by earnings


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

MCOV B logo
Medicover
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

Acquisitions In Romania And Turkey Will Create New Opportunities

Key Takeaways Strategic acquisitions and expansions position Medicover for significant growth in margins and profitability across multiple regions. Operational leverage and strong performance in diagnostics support ongoing revenue growth and enhanced earnings in core markets.
View narrative
SEK 220.21
FV
11.3% overvalued intrinsic discount
12.64%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
13 days ago author updated this narrative
View Medicover Community

Medicover AB (publ) Competitors

Asker Healthcare Group

OM:ASKER

SEK 35.6b

Dedicare

OM:DEDI

SEK 415.0m

Getinge

OM:GETI B

SEK 52.8b

Attendo

OM:ATT

SEK 9.1b

Price History & Performance

Summary of share price highs, lows and changes for Medicover
Historical stock prices
Current Share PriceSEK 245.00
52 Week HighSEK 247.50
52 Week LowSEK 170.40
Beta1.54
1 Month Change21.89%
3 Month Change18.36%
1 Year Change25.13%
3 Year Change41.78%
5 Year Change160.64%
Change since IPO274.05%

Recent News & Updates

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09
Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Recent updates

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09
Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 28
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Apr 14
Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Mar 21
Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively
author-image

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Feb 09 Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Shareholder Returns

MCOV BSE HealthcareSE Market
7D1.9%-0.003%4.0%
1Y25.1%32.2%-2.8%

Return vs Industry: MCOV B underperformed the Swedish Healthcare industry which returned 33.5% over the past year.

Return vs Market: MCOV B exceeded the Swedish Market which returned -2.2% over the past year.

Price Volatility

Is MCOV B's price volatile compared to industry and market?
MCOV B volatility
MCOV B Average Weekly Movement5.6%
Healthcare Industry Average Movement5.2%
Market Average Movement6.9%
10% most volatile stocks in SE Market13.7%
10% least volatile stocks in SE Market4.2%

Stable Share Price: MCOV B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: MCOV B's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199547,000John Stubbingtonwww.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.

Medicover AB (publ) Fundamentals Summary

How do Medicover's earnings and revenue compare to its market cap?
MCOV B fundamental statistics
Market capSEK 36.78b
Earnings (TTM)SEK 332.80m
Revenue (TTM)SEK 23.61b

110.5x

P/E Ratio

1.6x

P/S Ratio

Is MCOV B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCOV B income statement (TTM)
Revenue€2.17b
Cost of Revenue€1.69b
Gross Profit€476.40m
Other Expenses€445.80m
Earnings€30.60m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 24, 2025

Earnings per share (EPS)0.20
Gross Margin21.94%
Net Profit Margin1.41%
Debt/Equity Ratio143.0%

How did MCOV B perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

74%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 04:19
End of Day Share Price 2025/05/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicover AB (publ) is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB